These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

626 related articles for article (PubMed ID: 30449777)

  • 21. Renal Vasculitis and Pauci-immune Glomerulonephritis Associated With Immune Checkpoint Inhibitors.
    Gallan AJ; Alexander E; Reid P; Kutuby F; Chang A; Henriksen KJ
    Am J Kidney Dis; 2019 Dec; 74(6):853-856. PubMed ID: 31204194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Dermatomyositis with squamous cell carcinoma of the lungs secondary to nivolumab treatment: a case report].
    Miyashita K; Kajikawa H; Utsunomiya T; Hosaka M; Naito Y; Tomimoto H
    Rinsho Shinkeigaku; 2020 Nov; 60(11):768-772. PubMed ID: 33115992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple nivolumab-induced CNS demyelination with spontaneous resolution in an asymptomatic metastatic melanoma patient.
    Pillonel V; Dunet V; Hottinger AF; Berthod G; Schiappacasse L; Peters S; Michielin O; Aedo-Lopez V
    J Immunother Cancer; 2019 Dec; 7(1):336. PubMed ID: 31791418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nivolumab-induced Myocarditis Successfully Treated with Corticosteroid Therapy: A Case Report and Review of the Literature.
    Matsuo K; Ishiguro T; Najama T; Shimizu Y; Kobayashi Y; Mutou M
    Intern Med; 2019 Aug; 58(16):2367-2372. PubMed ID: 31118387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nivolumab-related severe thrombocytopenia in a patient with relapsed lung adenocarcinoma: a case report and review of the literature.
    Hasegawa T; Ozaki Y; Inoue T; Watanabe Y; Fukuhara M; Yamaura T; Muto S; Okabe N; Higuchi M; Shio Y; Suzuki H
    J Med Case Rep; 2019 Oct; 13(1):316. PubMed ID: 31647029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-transcriptional intermediary factor 1-γ antibody-positive dermatomyositis induced by nivolumab for lung adenocarcinoma: A case report.
    Osaki M; Tachikawa R; Ohira J; Hara S; Tomii K
    Invest New Drugs; 2021 Feb; 39(1):251-255. PubMed ID: 32651759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Organizing Pneumonia after Nivolumab Treatment in a Patient with Pathologically Proven Idiopathic Pulmonary Fibrosis.
    Kashiwada T; Minegishi Y; Saito Y; Kato T; Atsumi K; Seike M; Kubota K; Terasaki Y; Gemma A
    J Nippon Med Sch; 2019; 86(1):43-47. PubMed ID: 30918156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thyroid dysfunction induced by nivolumab: searching for disease patterns and outcomes.
    Peiró I; Palmero R; Iglesias P; Díez JJ; Simó-Servat A; Marín JA; Jiménez L; Domingo-Domenech E; Mancho-Fora N; Nadal E; Villabona C
    Endocrine; 2019 Jun; 64(3):605-613. PubMed ID: 30805887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pneumonitis in Irradiated Lungs After Nivolumab: A Brief Communication and Review of the Literature.
    Manapov F; Roengvoraphoj O; Dantes M; Marschner S; Li M; Eze C
    J Immunother; 2018; 41(2):96-99. PubMed ID: 29200082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 79-year Old Man on Nivolumab with Itchy Erythematous Patches.
    Copur MS; Corey S
    Oncology (Williston Park); 2020 Feb; 34(2):53-54. PubMed ID: 32645195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolated adrenocorticotropic hormone deficiency and thyroiditis associated with nivolumab therapy in a patient with advanced lung adenocarcinoma: a case report and review of the literature.
    Ohara N; Kobayashi M; Ohashi K; Ito R; Ikeda Y; Kawaguchi G; Yoneoka Y; Hasegawa G; Takada T
    J Med Case Rep; 2019 Mar; 13(1):88. PubMed ID: 30909965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of Immune Reaction in Benign Melanocytic Nevi Without Halo During Nivolumab Therapy in a Patient With Melanoma.
    Nakamura Y; Fujino T; Kagamu H; Matsuya T; Teramoto Y; Asami Y; Yamamoto A
    JAMA Dermatol; 2017 Aug; 153(8):832-834. PubMed ID: 28492864
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effectiveness of a Low-dose Corticosteroid in a Patient with Polymyalgia Rheumatica Associated with Nivolumab Treatment].
    Imai Y; Tanaka M; Fujii R; Uchitani K; Okazaki K
    Yakugaku Zasshi; 2019; 139(3):491-495. PubMed ID: 30828027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An unusual skin reaction in uveal melanoma during treatment with nivolumab: extragenital lichen sclerosus.
    Veronesi G; Scarfì F; Misciali C; Tartari F; Melotti B; Patrizi A; Dika E
    Anticancer Drugs; 2019 Oct; 30(9):969-972. PubMed ID: 31205068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe hemophagocytic lymphohistiocytosis in a melanoma patient treated with ipilimumab + nivolumab.
    Hantel A; Gabster B; Cheng JX; Golomb H; Gajewski TF
    J Immunother Cancer; 2018 Jul; 6(1):73. PubMed ID: 30012206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nivolumab-induced hypothyoidism with consequent hypothyroid related myopathy.
    Johnson ED; Kerrigan K; Butler K; Patel SB
    J Oncol Pharm Pract; 2020 Jan; 26(1):224-227. PubMed ID: 30880569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paraneoplastic dermatomyositis appearing after nivolumab therapy for gastric cancer: a case report.
    Shibata C; Kato J; Toda N; Imai M; Fukumura Y; Arai J; Kurokawa K; Kondo M; Takagi K; Kojima K; Ohki T; Seki M; Yoshida M; Suzuki A; Tagawa K
    J Med Case Rep; 2019 Jun; 13(1):168. PubMed ID: 31153385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune-related intestinal pseudo-obstruction associated with nivolumab treatment in a lung cancer patient.
    Fragulidis G; Pantiora E; Michalaki V; Kontis E; Primetis E; Vezakis A; Polydorou A
    J Oncol Pharm Pract; 2019 Mar; 25(2):487-491. PubMed ID: 29067858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exposure-Response Analysis of Nivolumab in Patients With Previously Treated or Untreated Advanced Melanoma.
    Bajaj G; Gupta M; Feng Y; Statkevich P; Roy A
    J Clin Pharmacol; 2017 Dec; 57(12):1527-1533. PubMed ID: 28800166
    [No Abstract]   [Full Text] [Related]  

  • 40. Nivolumab-Associated Guillain-Barre Syndrome in a Patient With Non-Small-Cell Lung Cancer.
    Thapa B; Khalid S; Vakili R; Ui J; Misbah S
    Am J Ther; 2018; 25(6):e761-e763. PubMed ID: 29889678
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.